| Affymax Announces Completion of Final Scheduled Data Monitoring Committee ... - Business Wire (press release) |
|
|
Business Wire (press release)In the Phase 3 program, Hematide is being evaluated to treat anemia in chronic renal failure patients on dialysis and not on dialysis. The Phase 3 program, ... read more |